Strategy

The total cost of ownership of a multisite MES project is inevitably higher than that of a single site. What are the other challenges of rolling out an MES across multiple, global sites and how can they be overcome?

Before a multisite MES project can be undertaken, the potential business benefits of the MES program must be defined.

Medical device manufacturers face a unique set of challenges where data and its management are concerned from an Industry 4.0 perspective.

The 2021 global chip shortage bears testimony that the industry’s perceived capabilities have fallen short on reaping the full potential of digital transformation and automation.

The Pygmalion effect of expecting the best results can be a key to deriving the benefits of change in a company. Knowing the company’s own value chain, placing clear expectations internally and in-line with a future, more digital self, followed by choosing the right MES and driving results through capable, motivated leadership, will deliver a digitally transformed enterprise.

While some industries, such as non-essential goods, were brought to a complete halt, other industries supplying goods to battle the disease (the Pharmaceutical, Clinical Diagnostic and Medical Device sectors), were expected to scale rapidly to meet the global demand for their products.

How does one implement an MES across multiple manufacturing plants, separated not just geographically but perhaps by operational style, IT infrastructure, work culture, and process technology?

What in the world does the IKEA effect have to do with software, and more specifically with MES? A truly modern MES application should, by virtue of its design, have the IKEA effect built in and as a part of its standard outlay.

As the medical device industry grows despite the pandemic (current research shows a 7% market growth) the need for an MES for process oversight and guidance becomes an even stronger argument.